MFG
HAE icon

Merit Financial Group’s Haemonetics HAE Stock Holding History

Merit Financial Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
+3,245
New +$208K ﹤0.01% 1965
2026
Q1 		– Sell
-3,514
Closed -$282K – 2155
2025
Q4 		$282K Buy
+3,514
New +$236K ﹤0.01% 1598

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Merit Financial Group's HAE Position: Q2 2026 in Review

Merit Financial Group opened a new position in Haemonetics (HAE) in Q2 2026: 3,245 shares worth $243K. The stake represents ﹤0.01% of the portfolio and ranks #1965 among its holdings. This is a return to the name: Merit Financial Group previously reported a position in HAE as recently as Q4 2025.

Merit Financial Group first reported a position in HAE in Q4 2025 and has held it in 2 quarters since. The position peaked at $282K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Merit Financial Group held 3,245 shares of Haemonetics worth $243K as of Q2 2026.
  • Haemonetics was a new Merit Financial Group position in Q2 2026.
  • Haemonetics made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #1965 holding.
  • Merit Financial Group first reported a position in Haemonetics in Q4 2025 and has held it in 2 quarters since.
  • Merit Financial Group's Haemonetics position peaked at $282K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.